checkAd
    Startseite > Aktien > Kymera Therapeutics > Nachrichten
    Kymera Therapeutics Aktie
    37,40
     
    USD
    +3,03 %
    +1,10 USD
    Letzter Kurs 02:00:00 Nasdaq
    37,31
     
    USD
    300 STK
    Geldkurs 03.05.24
    37,40
     
    USD
    4.000 STK
    Briefkurs 03.05.24
    ISIN: US5015751044 · WKN: A2QBSH · SYM: KYMR · USA

    Neueste Nachrichten

    Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
    02.05.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2
    25.04.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting
    08.04.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting
    08.03.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics to Participate in Upcoming March Investor Conferences
    28.02.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
    22.02.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 22
    15.02.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference
    31.01.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Outlines Key 2024 Objectives and Strategy to Progress Leading Portfolio of Immunology and Oncology Programs
    09.01.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    09.01.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Announces Pricing of $275 Million Public Offering
    05.01.24 · globenewswire · Kymera Therapeutics
    Kymera Therapeutics Announces Proposed Public Offering
    04.01.24 · globenewswire · Kymera Therapeutics